Article Information
History
- April 13, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mark Jarrett, MD, MBA, MS1,*,
- Warren B. Licht, MD1,
- Kevin Bock, MD, MHCDS1,
- Zenobia Brown, MD, MPH1,
- Jamie S. Hirsch, MD, MA, MSB1,
- Kevin Coppa, BS2,
- Rajdeep Brar, MD2,
- Steven Bello, PA, MHCDS3 and
- Ira S. Nash, MD1
- 1Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA
- 2Department of Information Services, Northwell Health, New Hyde Park, New York, USA
- 3Northwell Health, Lake Success, New York, USA
- ↵*Corresponding Author: Mark Jarrett MD, MBA, MS, 2000 Marcus Avenue, New Hyde Park, NY 11042, mjarrett{at}northwell.edu, Phone: 516-321-6044, Cell: 917-796-3935
Posted April 13, 2021.
Early Experience With Neutralizing Monoclonal Antibody Therapy For COVID-19
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
Author Videos